Trial NCT04933942

View at ClinicalTrials.gov 
Org. Study IDs: EORTC-1926-BTG

Last trial update was posted on 2023-05-24

MeSH Interventions

Lomustine

MeSH Conditions

Disease Progression Glioblastoma Thrombocytopenia

Other Conditions

First Progression of MGMT Promoter-methylated Glioblastoma

Stopping Reasons

Amgen withdrew interest in providing further financial support

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID